Evogene (NASDAQ:EVGN) Price Target Cut to $12.00 by Analysts at Lake Street Capital

Evogene (NASDAQ:EVGN) had its target price cut by Lake Street Capital from $30.00 to $12.00 in a research report report published on Friday morning, Benzinga reports. They currently have a buy rating on the biotechnology company’s stock.

Separately, StockNews.com began coverage on Evogene in a report on Thursday. They issued a sell rating on the stock.

Evogene Stock Up 9.3 %

Shares of EVGN opened at $3.88 on Friday. The business has a fifty day moving average of $5.35 and a 200 day moving average of $6.79. The company has a market cap of $159.92 million, a PE ratio of -8.43 and a beta of 1.40. Evogene has a 52-week low of $3.45 and a 52-week high of $10.40.

Evogene (NASDAQ:EVGN) last released its earnings results on Thursday, August 22nd. The biotechnology company reported ($1.06) earnings per share (EPS) for the quarter. The firm had revenue of $0.91 million during the quarter. Evogene had a negative return on equity of 70.96% and a negative net margin of 233.66%.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Evogene stock. BNP Paribas Financial Markets grew its stake in Evogene Ltd. (NASDAQ:EVGN) by 30.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 91,400 shares of the biotechnology company’s stock after acquiring an additional 21,500 shares during the period. BNP Paribas Financial Markets owned 0.22% of Evogene worth $69,000 at the end of the most recent reporting period. Institutional investors own 10.40% of the company’s stock.

Evogene Company Profile

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications.